These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7919127)

  • 1. Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors.
    Leto G; Pizzolanti G; Tumminello FM; Gebbia N
    In Vivo; 1994; 8(2):231-6. PubMed ID: 7919127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
    Leto G; Tumminello FM; Gebbia N; Woynarowska B; Bernacki RJ
    Anticancer Res; 1990; 10(1):265-9. PubMed ID: 2334138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
    Navab R; Mort JS; Brodt P
    Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
    Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
    Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinases in renal cell death.
    Yang X; Schnellmann RG
    J Toxicol Environ Health; 1996 Jul; 48(4):319-32. PubMed ID: 8691504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
    Khalikova TA; Korolenko TA; Il'nitskaia SI
    Biomed Khim; 2009; 55(5):621-34. PubMed ID: 20017393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cysteine and aspartyl proteinases in the alfalfa weevil midgut with biochemical and plant-derived proteinase inhibitors.
    Wilhite SE; Elden TC; Brzin J; Smigocki AC
    Insect Biochem Mol Biol; 2000 Dec; 30(12):1181-8. PubMed ID: 11044664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.
    Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T
    Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cysteine protease inhibitor Ep-475 on TNF-alpha-independent cyclophosphamide-induced apoptosis in mouse lymphosarcoma LS cells.
    Zhanaeva SY; Korolenko TA; Khoshchenko OM; Spiridonov VK; Nikolin VP; Kaledin VI
    Bull Exp Biol Med; 2005 Feb; 139(2):186-9. PubMed ID: 16027802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.
    Sever N; Filipic M; Brzin J; Lah TT
    Biol Chem; 2002 May; 383(5):839-42. PubMed ID: 12108549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas.
    Castino R; Pace D; Démoz M; Gargiulo M; Ariatta C; Raiteri E; Isidoro C
    Int J Cancer; 2002 Feb; 97(6):775-9. PubMed ID: 11857353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.
    Ménard R; Therrien C; Lachance P; Sulea T; Qo H; Alvarez-Hernandez AD; Roush WR
    Biol Chem; 2001 May; 382(5):839-45. PubMed ID: 11517939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L.
    Katunuma N; Towatari T; Kominami E; Hashida S; Takio K; Titani K
    Acta Biol Med Ger; 1981; 40(10-11):1419-25. PubMed ID: 6177136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lysosomal proteinase inhibition on the development of the rat embryo in vitro.
    Daston GP; Baines D; Yonker JE; Lehman-McKeeman LD
    Teratology; 1991 Mar; 43(3):253-61. PubMed ID: 2014487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cathepsin B- and L-like proteinases in silk gland histolysis during metamorphosis of Bombyx mori.
    Shiba H; Uchida D; Kobayashi H; Natori M
    Arch Biochem Biophys; 2001 Jun; 390(1):28-34. PubMed ID: 11368511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor).
    Bailly E; Jambou R; Savel J; Jaureguiberry G
    J Protozool; 1992; 39(5):593-9. PubMed ID: 1522541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle aspartyl protease (cathepsin D) activity: detection using a chromophoric substrate and relation to wasting in DBA/2 mice implanted with leukemic L1210 tumor cells.
    Bolger GT; Jaramillo J
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1141-8. PubMed ID: 9022834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.